Correlation Between CSL and Zealand Pharma
Can any of the company-specific risk be diversified away by investing in both CSL and Zealand Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CSL and Zealand Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CSL and Zealand Pharma AS, you can compare the effects of market volatilities on CSL and Zealand Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CSL with a short position of Zealand Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of CSL and Zealand Pharma.
Diversification Opportunities for CSL and Zealand Pharma
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between CSL and Zealand is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding CSL and Zealand Pharma AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zealand Pharma AS and CSL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CSL are associated (or correlated) with Zealand Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zealand Pharma AS has no effect on the direction of CSL i.e., CSL and Zealand Pharma go up and down completely randomly.
Pair Corralation between CSL and Zealand Pharma
Assuming the 90 days horizon CSL is expected to generate 0.32 times more return on investment than Zealand Pharma. However, CSL is 3.15 times less risky than Zealand Pharma. It trades about -0.14 of its potential returns per unit of risk. Zealand Pharma AS is currently generating about -0.15 per unit of risk. If you would invest 9,495 in CSL on August 31, 2024 and sell it today you would lose (376.00) from holding CSL or give up 3.96% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
CSL vs. Zealand Pharma AS
Performance |
| Timeline |
| CSL |
| Zealand Pharma AS |
CSL and Zealand Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CSL and Zealand Pharma
The main advantage of trading using opposite CSL and Zealand Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CSL position performs unexpectedly, Zealand Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zealand Pharma will offset losses from the drop in Zealand Pharma's long position.The idea behind CSL and Zealand Pharma AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Zealand Pharma vs. NewAmsterdam Pharma | Zealand Pharma vs. Portage Biotech | Zealand Pharma vs. DBV Technologies | Zealand Pharma vs. NewAmsterdam Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |